期刊文献+

两种微创术式治疗甲状腺微小乳头状癌的疗效及对氧化应激指标的影响 被引量:4

Effect of Two Minimally Invasive Procedures in the Treatment of Papillary Thyroid Microcarcinoma and Their Influence on Oxidative Stress Indicators
下载PDF
导出
摘要 目的探讨两种微创术式对甲状腺微小乳头状癌的临床治疗价值。方法选取2018年7月至2020年6月收治的84例甲状腺微小乳头状癌患者,以随机数字表法分组,观察组42例,行改良Miccoli手术,对照组42例,行完全腔镜手术,对两组患者手术及术后恢复情况,术后疼痛程度,术前、术后48h氧化应激指标变化,术后并发症予以观察。结果与对照组比较,观察组术中出血量明显较少,手术时间、术后引流时间、术后住院时间明显较短(P<0.05),两组淋巴结清扫数比较,无明显差异(P>0.05);观察组术后12h、术后24h、术后48h视觉模拟评分法(VAS)评分与同期对照组比较,明显较低(P<0.05);术前,两组血清谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、丙二醛(MDA)水平比较,无明显差异(P>0.05),术后48h,观察组上述指标情况与同期对照组比较,明显较好(P<0.05);观察组术后并发症发生率为4.76%,与对照组7.14%比较,无明显差异(P>0.05)。结论改良Miccoli手术与完全腔镜手术治疗甲状腺微小乳头状癌均具有较好效果及安全性,但改良Miccoli手术可减少手术时间及术中出血量,减轻术后疼痛,降低术后氧化应激指标水平,更利于术后恢复。 Objective To explore the clinical value of two minimally invasive procedures for papillary thyroid microcarcinoma.Methods A total of 84 patients with papillary thyroid microcarcinoma admitted from July 2018 to June 2020 were divided into two groups by the random number table method,42 cases in the observation group underwent modified Miccoli operation,42 cases in the control group underwent complete laparoscopic operation.The operation and postoperative recovery,the degree of postoperative pain,the changes of oxidative stress indicators before and 48h after operation,the postoperative complications of the two groups were observed.Results Compared with the control group,the intraoperative blood loss of the observation group was significantly less,the operation time,postoperative drainage time and postoperative hospital stay of the observation group were significantly shorter(P<0.05),there was no significant difference in the number of lymph node dissections between the two groups(P>0.05).The visual analogue scale(VAS)scores of the observation group at 12h,24h,and 48h after operation were compared with the control group at the same period,significantly lower(P<0.05).Before operation,there were no significant difference in the serum glutathione peroxidase(GSH-Px),superoxide dismutase(SOD)and malondialdehyde(MDA)levels between the two groups(P>0.05),48h after operation,compared with the control group at the same period,the above indicators in the observation group were obviously better(P<0.05).The incidence of postoperative complications in the observation group was 4.76%,compared with 7.14%in the control group,had no significant difference(P>0.05).Conclusion Modified Miccoli operation and complete laparoscopic soperation for the treatment of papillary thyroid microcarcinoma are both effective and safe,but modified Miccoli operation can reduce operation time and intraoperative blood loss,reduce postoperative pain,and reduce postoperative oxidative stress indicators levels,it is more conducive to postoperative recovery.
作者 郜峰 GAO Feng(Department of General Surgery,Shaoling District People's Hospital of Luohe City,Luohe 462300,Henan Province,China)
出处 《罕少疾病杂志》 2022年第1期30-32,共3页 Journal of Rare and Uncommon Diseases
关键词 甲状腺微小乳头状癌 改良Miccoli手术 完全腔镜手术 氧化应激指标 Papillary Thyroid Microcarcinoma Modified Miccoli Operation Complete Laparoscopic Operation Oxidative Stress Index
  • 相关文献

参考文献12

二级参考文献156

  • 1李侠,项本宏.微创治疗甲状腺癌的疗效及对其创伤应激和预后的影响评估[J].湖南师范大学学报(医学版),2019,16(4):167-169. 被引量:10
  • 2American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 3Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 4Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 5Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 6De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 7Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 8Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 9Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 10Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.

共引文献498

同被引文献44

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部